1,263.25
Netflix Inc stock is traded at $1,263.25, with a volume of 2.21M.
It is up +1.49% in the last 24 hours and up +4.26% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$1,244.76
Open:
$1246.67
24h Volume:
2.21M
Relative Volume:
0.72
Market Cap:
$536.79B
Revenue:
$41.46B
Net Income/Loss:
$10.25B
P/E Ratio:
53.82
EPS:
23.47
Net Cash Flow:
$8.50B
1W Performance:
+4.05%
1M Performance:
+4.26%
6M Performance:
+41.76%
1Y Performance:
+87.03%
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,263.25 | 528.93B | 41.46B | 10.25B | 8.50B | 23.47 |
![]()
DIS
Walt Disney Co
|
117.37 | 213.67B | 94.13B | 12.55B | 11.55B | 6.38 |
![]()
LYV
Live Nation Entertainment Inc
|
170.30 | 39.29B | 23.72B | 775.11M | 1.08B | 2.31 |
![]()
WBD
Warner Bros Discovery Inc
|
12.26 | 30.58B | 38.41B | 640.00M | 4.07B | 0.30 |
![]()
FWONK
Liberty Media Corp
|
101.49 | 25.46B | 3.51B | -102.00M | 737.00M | -0.42 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
Jul-02-25 | Reiterated | Goldman | Neutral |
Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
Jun-12-25 | Reiterated | Oppenheimer | Outperform |
Jun-03-25 | Reiterated | Jefferies | Buy |
May-30-25 | Reiterated | BofA Securities | Buy |
May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
Apr-21-25 | Reiterated | Barclays | Equal Weight |
Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
Apr-21-25 | Reiterated | Guggenheim | Buy |
Apr-21-25 | Reiterated | JP Morgan | Overweight |
Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
Apr-21-25 | Reiterated | MoffettNathanson | Buy |
Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
Apr-21-25 | Reiterated | Oppenheimer | Outperform |
Apr-21-25 | Reiterated | Piper Sandler | Overweight |
Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
Apr-21-25 | Reiterated | Wells Fargo | Overweight |
Apr-17-25 | Resumed | Piper Sandler | Overweight |
Mar-27-25 | Initiated | FBN Securities | Outperform |
Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
Jan-22-25 | Reiterated | Oppenheimer | Outperform |
Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
Jan-15-25 | Reiterated | Oppenheimer | Outperform |
Jan-08-25 | Reiterated | Goldman | Neutral |
Jan-06-25 | Reiterated | Argus | Buy |
Jan-03-25 | Reiterated | The Benchmark Company | Sell |
Dec-19-24 | Reiterated | UBS | Buy |
Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
Dec-16-24 | Reiterated | Oppenheimer | Outperform |
Dec-11-24 | Reiterated | JP Morgan | Overweight |
Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
Oct-18-24 | Reiterated | Needham | Buy |
Oct-18-24 | Reiterated | Oppenheimer | Outperform |
Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
Oct-16-24 | Reiterated | Loop Capital | Buy |
Oct-11-24 | Reiterated | Guggenheim | Buy |
Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
Oct-10-24 | Reiterated | Oppenheimer | Outperform |
Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Sep-05-24 | Initiated | China Renaissance | Hold |
Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
Jul-17-24 | Reiterated | Guggenheim | Buy |
Jul-16-24 | Reiterated | The Benchmark Company | Sell |
Jul-15-24 | Reiterated | BofA Securities | Buy |
Jul-12-24 | Reiterated | JP Morgan | Overweight |
Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-09-24 | Reiterated | TD Cowen | Buy |
Jul-02-24 | Reiterated | Argus | Buy |
May-28-24 | Reiterated | Evercore ISI | Outperform |
Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Apr-19-24 | Upgrade | Needham | Hold → Buy |
Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
Apr-15-24 | Reiterated | Deutsche Bank | Hold |
Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
Apr-12-24 | Reiterated | Piper Sandler | Neutral |
Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
Mar-25-24 | Reiterated | Citigroup | Neutral |
Mar-12-24 | Reiterated | Jefferies | Buy |
Mar-11-24 | Reiterated | Oppenheimer | Outperform |
Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
Jan-24-24 | Reiterated | BofA Securities | Buy |
Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
Jan-24-24 | Reiterated | Evercore ISI | Outperform |
Jan-24-24 | Reiterated | Goldman | Neutral |
Jan-24-24 | Reiterated | Guggenheim | Buy |
Jan-24-24 | Reiterated | JP Morgan | Overweight |
Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
Jan-24-24 | Reiterated | Oppenheimer | Outperform |
Jan-24-24 | Reiterated | Piper Sandler | Neutral |
Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
Jan-24-24 | Reiterated | TD Cowen | Outperform |
Jan-24-24 | Reiterated | UBS | Buy |
Jan-24-24 | Reiterated | Wells Fargo | Overweight |
Sep-18-23 | Reiterated | Evercore ISI | Outperform |
Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jul-17-23 | Reiterated | Deutsche Bank | Buy |
Jul-13-23 | Reiterated | JP Morgan | Overweight |
Jul-12-23 | Reiterated | UBS | Buy |
Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
Jun-29-23 | Reiterated | Citigroup | Buy |
Jun-28-23 | Reiterated | Oppenheimer | Outperform |
Jun-13-23 | Reiterated | BofA Securities | Buy |
Jun-13-23 | Reiterated | Guggenheim | Buy |
Apr-19-23 | Reiterated | Deutsche Bank | Buy |
Apr-19-23 | Reiterated | JP Morgan | Overweight |
Apr-19-23 | Reiterated | Jefferies | Buy |
Apr-19-23 | Reiterated | Piper Sandler | Neutral |
Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
Apr-19-23 | Reiterated | Rosenblatt | Neutral |
Apr-19-23 | Upgrade | UBS | Neutral → Buy |
Apr-11-23 | Resumed | Robert W. Baird | Neutral |
Jan-23-23 | Reiterated | Argus | Buy |
Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
Jan-20-23 | Reiterated | Deutsche Bank | Buy |
Jan-20-23 | Reiterated | Evercore ISI | Outperform |
Jan-20-23 | Reiterated | Goldman | Sell |
Jan-20-23 | Reiterated | Guggenheim | Buy |
Jan-20-23 | Reiterated | Jefferies | Buy |
Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
Jan-20-23 | Reiterated | Oppenheimer | Outperform |
Jan-20-23 | Reiterated | Piper Sandler | Neutral |
Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
Jan-20-23 | Reiterated | The Benchmark Company | Sell |
Jan-20-23 | Reiterated | Wedbush | Outperform |
Jan-20-23 | Reiterated | Wolfe Research | Outperform |
Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
Jan-04-23 | Initiated | New Street | Neutral |
Dec-29-22 | Upgrade | CFRA | Sell → Buy |
Dec-14-22 | Reiterated | Jefferies | Hold |
Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-20-22 | Upgrade | Needham | Underperform → Hold |
Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
Apr-20-22 | Downgrade | Stifel | Buy → Hold |
Apr-20-22 | Downgrade | UBS | Buy → Neutral |
Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-19-22 | Initiated | Rosenblatt | Neutral |
Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
Jan-21-22 | Reiterated | BofA Securities | Buy |
Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
Jan-21-22 | Reiterated | Cowen | Outperform |
Jan-21-22 | Reiterated | Deutsche Bank | Hold |
Jan-21-22 | Reiterated | Goldman | Neutral |
Jan-21-22 | Reiterated | Guggenheim | Buy |
Jan-21-22 | Reiterated | JP Morgan | Overweight |
Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-21-22 | Reiterated | Oppenheimer | Outperform |
Jan-21-22 | Reiterated | Piper Sandler | Overweight |
Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-21-22 | Reiterated | Stifel | Buy |
Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-21-22 | Downgrade | Truist | Buy → Hold |
Jan-21-22 | Reiterated | UBS | Buy |
Jan-21-22 | Reiterated | Wolfe Research | Outperform |
Dec-15-21 | Reiterated | The Benchmark Company | Sell |
Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Sep-29-21 | Reiterated | The Benchmark Company | Sell |
Sep-13-21 | Initiated | Goldman | Neutral |
Sep-08-21 | Reiterated | JP Morgan | Overweight |
Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
Jul-21-21 | Reiterated | Credit Suisse | Outperform |
Jul-21-21 | Reiterated | Deutsche Bank | Buy |
Jul-21-21 | Reiterated | JP Morgan | Overweight |
Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-21-21 | Reiterated | Stifel | Buy |
Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-25-21 | Initiated | Edward Jones | Hold |
May-19-21 | Resumed | Jefferies | Buy |
Apr-21-21 | Resumed | Oppenheimer | Outperform |
Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
Apr-21-21 | Upgrade | Stifel | Hold → Buy |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Apr-01-21 | Initiated | Piper Sandler | Overweight |
Mar-25-21 | Reiterated | The Benchmark Company | Sell |
Mar-23-21 | Upgrade | Argus | Hold → Buy |
Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
Jan-20-21 | Reiterated | The Benchmark Company | Sell |
Jan-20-21 | Upgrade | UBS | Neutral → Buy |
Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
Oct-21-20 | Reiterated | Bernstein | Outperform |
Oct-21-20 | Reiterated | Jefferies | Buy |
Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
Oct-21-20 | Reiterated | Oppenheimer | Outperform |
Oct-21-20 | Reiterated | Piper Sandler | Overweight |
Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
Oct-21-20 | Reiterated | The Benchmark Company | Sell |
Oct-21-20 | Reiterated | Wedbush | Underperform |
Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
Oct-14-20 | Reiterated | Goldman | Buy |
Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
Sep-28-20 | Reiterated | The Benchmark Company | Sell |
Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-09-20 | Resumed | Raymond James | Mkt Perform |
Sep-04-20 | Reiterated | The Benchmark Company | Sell |
Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Here's What Broadcom Hitting an All-Time High Means for the "Magnificent Seven" and the "Ten Titans" Growth Stocks - The Motley Fool
Petrus Trust Company LTA Purchases Shares of 557 Netflix, Inc. $NFLX - MarketBeat
Gerard Butler's 82% RT Rated Action Thriller Is Already Leaving Netflix After Becoming a Streaming Hit - MovieWeb
Netflix (NFLX) Rises Higher Than Market: Key Facts - Yahoo Finance
NatWest Group plc Decreases Holdings in Netflix, Inc. $NFLX - MarketBeat
‘Wednesday’ Season 2 Part 2 Opens to 28 Million Views on Netflix, Down 43% From Part 1 - IMDb
Netflix, Inc. $NFLX Stock Position Increased by Night Owl Capital Management LLC - MarketBeat
Black Mirror Creator Announces Detective Series Starring Game of Thrones, House of the Dragon & Barbarian Stars - Comic Book Resources
Game of Thrones icon confirmed for Black Mirror creator's bloody new crime thriller - Radio Times
‘Black Mirror’ Creator Charlie Brooker Reveals Next Netflix Show - IMDb
Charlie Sheen Makes Plea to Jon Cryer After Netflix Documentary & Years-Long Rift - Princeton Clarion
‘Black Mirror’ Creator Charlie Brooker Sets Crime Thriller Series at Netflix With Paddy Considine, Georgina Campbell and Lena Headey to Star - IMDb
Netflix’s (NFLX) Results Exceeded Expectations Amid Macroeconomic Challenges - Insider Monkey
Charlie Brooker Making Netflix Detective Series Starring Paddy Considine, Georgina Campbell & Lena Headey - Deadline
Great Lakes Advisors LLC Cuts Stock Position in Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Stock Position Increased by Ascent Group LLC - MarketBeat
Meiji Yasuda Life Insurance Co Sells 1,356 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Position Reduced by Meiji Yasuda Asset Management Co Ltd. - MarketBeat
Caxton Associates LLP Purchases New Position in Netflix, Inc. $NFLX - MarketBeat
Teza Capital Management LLC Has $298,000 Stock Position in Netflix, Inc. $NFLX - MarketBeat
Tim Robinson's new HBO Max TV show arrives in October, and I'm already hooked by its single sentence story synopsis - TechRadar
Jericho Capital Asset Management L.P. Sells 240,000 Shares of Netflix, Inc. $NFLX - MarketBeat
Kettle Hill Capital Management LLC Takes $11.28 Million Position in Netflix, Inc. $NFLX - MarketBeat
Precision Trading with Netflix Inc. (NFLX) Risk Zones - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 2,948 Shares of Netflix, Inc. $NFLX - MarketBeat
Nightview Capital LLC Purchases Shares of 6,101 Netflix, Inc. $NFLX - MarketBeat
DoubleLine ETF Adviser LP Sells 1,833 Shares of Netflix, Inc. $NFLX - MarketBeat
Im Si-wan, Park Gyu-young, Jo Woo-jin clash in 'Mantis' - 조선일보
Netflix, Inc. $NFLX Shares Sold by EFG Asset Management North America Corp. - MarketBeat
Polar Asset Management Partners Inc. Sells 12,800 Shares of Netflix, Inc. $NFLX - MarketBeat
Pierce Brosnan ‘Gobsmacked’ By ‘Thursday Murder Club’ Talent - Hollywood Outbreak
Netflix Sets Premiere for ‘Tomb Raider: The Legend of Lara Croft’ Finale Second Season - Animation Magazine
Netflix at Goldman Sachs Conference: Strategic Growth Insights - Investing.com
Lena Dunham Developing 'Sex Act' TV Series Starring Sarah Paulson For Netflix - Deadline
Adam Sandler Is the Closest Thing We Have to a Hollywood Golden Age Star - MovieWeb
Transcript : Netflix, Inc. Presents at Goldman Sachs Communicopia + Technology Conference 2025, Sep-08-2025 01 - MarketScreener
Netflix, Inc. (NFLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
‘Bet’ Star Miku Martineau to Lead Netflix YA Series ‘Crew Girl’ - IMDb
YouTube Averages 17.3 Million Viewers In NFL Debut: How The Numbers Compare To Amazon & Netflix - Benzinga
Advisors Asset Management Inc. Acquires 1,754 Shares of Netflix, Inc. $NFLX - MarketBeat
‘Leanne’ Renewed for Season 2 at Netflix - IMDb
Leanne Morgan Comedy Series Is Renewed for Season 2 - IMDb
‘Leanne’ Renewed for Second Season at Netflix - IMDb
Leanne Renewed for Season 2 at Netflix - IMDb
Leanne Morgan’s Comedy Series Leanne Will Return for Season 2 - Netflix
NFLX's Advertising Revenues Fuel Top-Line Growth: Is It Sustainable? - The Globe and Mail
Podcast: Cecilie Fjellhøy on Netflix’s Love Con Revenge – ‘They hack our emotions’ - Yahoo News Singapore
Teewinot Capital Advisers L.L.C. Acquires 2,667 Shares of Netflix, Inc. $NFLX - MarketBeat
A Fresh Look at Netflix (NFLX) Valuation as Live Sports and New Features Fuel Growth Momentum - Yahoo Finance
Laidlaw Wealth Management LLC Sells 842 Shares of Netflix, Inc. $NFLX - MarketBeat
Everstar Asset Management LLC Acquires New Holdings in Netflix, Inc. $NFLX - MarketBeat
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):